Hemo Flow Explained: Testosterone, Red Blood Cells, and Blood Clot Risks
Truth Rating
Hemo Flow aims to reduce blood viscosity and hematocrit associated with testosterone use. While ingredients like VasoDrive-AP and Nattokinase have clinical backing for circulation, claims of a 'hematocrit drop' rely on anecdotes.
Hemo Flow aims to reduce blood viscosity and hematocrit associated with testosterone use. While ingredients like VasoDrive-AP and Nattokinase have clinical backing for circulation, claims of a 'hematocrit drop' rely on anecdotes.
🔥Hot Take:
- The speaker uses anecdotal customer emails as 'proof' for clinical outcomes, which is the definition of selective framing.
- While Nattokinase is a legit fibrinolytic, claiming it replaces the need for medical phlebotomy (donating blood) is a dangerous medical overreach.
🔥Hot Take:
- •The speaker uses anecdotal customer emails as 'proof' for clinical outcomes, which is the definition of selective framing.
- •While Nattokinase is a legit fibrinolytic, claiming it replaces the need for medical phlebotomy (donating blood) is a dangerous medical overreach.
Claim Breakdown:
📝 Fact Check: This is a well-documented medical fact. Testosterone stimulates erythropoiesis (red blood cell production), which can lead to secondary polycythemia, increasing blood viscosity and cardiovascular risk.
Fact Check Date: January 9, 2026
IMPORTANT WARNING
Disclaimer: This tool provides general informational content and is not a substitute for personalised, professional advice.
Recent BS Checks